Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: a Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort
Pregnancy and Breastfeeding: Limited but reassuring data suggests topical copper peptides at standard cosmetic concentrations are unlikely to pose risks during pregnancy or breastfeeding
In two positive Phase III trials, it met all primary and secondary endpoints with strong efficacy and tolerability
The relationship between dose, route of administration, and clinical outcomes requires systematic investigation to establish therapeutic ranges and maximize efficacy while minimizing potential risks
Nitric oxide is the endothelial factor responsible for relaxation of smooth musculature surrounding the arterials and the pre-capillary sphincters thereby producing vasodilation and increased blood flow into the capillary bed of the exercising muscle tissue
However, it is not FDA-approved for medical treatment or injection, and regulatory status may vary by use
